Co-Authors
This is a "connection" page, showing publications co-authored by Christof von Kalle and Victor Corman.
Connection Strength
0.290
-
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study. Lancet Respir Med. 2021 11; 9(11):1255-1265.
Score: 0.060
-
Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany. Emerg Infect Dis. 2021 08; 27(8):2174-2178.
Score: 0.059
-
Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study. Infection. 2021 Aug; 49(4):703-714.
Score: 0.059
-
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell. 2020 09 17; 182(6):1419-1440.e23.
Score: 0.056
-
Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19). Infection. 2020 Aug; 48(4):619-626.
Score: 0.055